000 01793 a2200493 4500
005 20250515181537.0
264 0 _c20091124
008 200911s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2009.07.053
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Callain Y
245 0 0 _aDiscovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cSep 2009
300 _a5029-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic Uptake Inhibitors
_xchemical synthesis
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents
_xchemical synthesis
650 0 4 _aCHO Cells
650 0 4 _aCell Line
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aCrystallography, X-Ray
650 0 4 _aDogs
650 0 4 _aDopamine Plasma Membrane Transport Proteins
_xantagonists & inhibitors
650 0 4 _aDrug Discovery
650 0 4 _aHumans
650 0 4 _aMolecular Conformation
650 0 4 _aNorepinephrine
_xantagonists & inhibitors
650 0 4 _aPropanols
_xchemical synthesis
650 0 4 _aRecombinant Proteins
_xantagonists & inhibitors
650 0 4 _aSerotonin Plasma Membrane Transport Proteins
_xmetabolism
650 0 4 _aStructure-Activity Relationship
700 1 _aMahaney, Paige E
700 1 _aMcConnell, Oliver
700 1 _aZhang, Yingru
700 1 _aManas, Eric
700 1 _aHo, Douglas M
700 1 _aDeecher, Darlene C
700 1 _aTrybulski, Eugene J
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 19
_gno. 17
_gp. 5029-32
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2009.07.053
_zAvailable from publisher's website
999 _c19040391
_d19040391